| Literature DB >> 30827063 |
Chulho Kim1, Sung-Eun Kim2, Jin Pyeong Jeon3,4,5.
Abstract
PURPOSE: To assess clinical and angiographic outcomes after endovascular treatment (EVT) in ischemic stroke patients according to anesthesia types (general anesthesia vs. conscious sedation).Entities:
Keywords: Anesthesia, General; Stroke
Year: 2019 PMID: 30827063 PMCID: PMC6433186 DOI: 10.5469/neuroint.2019.00045
Source DB: PubMed Journal: Neurointervention ISSN: 2093-9043
Clinical data of the studies included in this meta-analysis
| Study | Center/design | Anesthesia type | Total No. | Age (years) | NIHSS | OTP (minutes) | IV-tPA | Good outcome | Successful recanalization | Complications | NOS |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mortality/S-ICH/pneumonia | |||||||||||
| Jumaa et al. [ | S/Retro | GA | 53 | 66.5 | 17.6 | NC | 20 (37.7) | 12 (22.6) | 37 (69.8) | 23/(-)/(-) | 8 |
| CS | 73 | 66.7 | 15.1 | NC | 20 (27.4) | 33(46.5)[ | 60 (82.2) | 16/(-)/(-) | |||
| Sugg et al. [ | S/Retro | GA | 9 | 78.3 | 28.3 | 271.0[ | NC | 1 (11.1) | 6 (66.7) | 5/(-)/(-) | 8 |
| CS | 57 | 65.9 | 17.1 | 260.0[ | NC | 29 (50.9) | 43 (75.4) | 17/(-)/(-) | |||
| Davis et al. [ | S/Retro | GA | 48 | 63 | 19.5[ | NC | NC | 7 (14.6) | NC | NC | 8 |
| CS | 48 | 62 | 16 | NC | NC | 29 (60.4) | NC | NC | |||
| Hassan et al. [ | M/Retro | GA | 53 | 67.7 | NC | NC | 24 (45.3) | 9[ | NC | 19[ | 7 |
| CS | 83 | 65.7 | NC | NC | 34 (41.0) | 37[ | NC | 7[ | |||
| Abou-Chebl et al. [ | M/Retro | GA | 196 | 66.4 | 18.9 | 337.4 | 368 (34.5) | 70 (35.6) | 144 (73.6) | 67/22/(-) | 7 |
| CS | 85 | 69 | 16.4 | 395.4 | 26 (30.6) | 45 (52.6) | 62 (72.9) | 20/6/(-) | |||
| Li et al. [ | S/Retro | GA | 35 | 62 | 18 | 300 | 4 (11.4) | 4[ | NC | 14[ | 8 |
| CS | 74 | 68 | 15 | 276 | 10 (13.5) | 11[ | NC | 16[ | |||
| Whalin et al. [ | S/Retro | GA | 133 | 63.5 | 20[ | 304[ | 70 (52.6) | 40 (30.1) | 96 (72.2) | (-)/8/15 | 8 |
| CS | 83 | 68.2 | 17[ | 292[ | 44 (53.0) | 40 (48.2) | 70 (84.3) | (-)/7/3 | |||
| John et al. [ | S/Retro | GA | 91 | 64.8 | 16.3 | NC | 29 (31.9) | 10[ | 52 (57.1) | 23[ | 7 |
| CS | 99 | 69.1 | 15.4 | NC | 39 (39.4) | 18[ | 47 (47.5) | 13[ | |||
| van den Berg et al. [ | M/Retro | GA | 70 | 57 | 16 | 241 | 45 (64.3) | 10[ | 34 (48.6) | 15[ | 8 |
| CS | 278 | 62 | 15 | 220 | 211 (75.9) | 72[ | 113 (40.6) | 46[ | |||
| Mundiyanapurath et al. [ | S/Pro | GA | 29 | 73[ | 21[ | NC | NC | NC | 20 (69.0) | NC | 6 |
| CS | 15 | 67[ | 17[ | NC | NC | NC | 8 (53.3) | NC | |||
| Schönenberger et al. [ | S/RCT | GA | 73 | 71.8 | 16.8 | NC | 46 (63.0) | 27 (37.0) | 65 (89.0) | 18/(-)/10 | - |
| CS | 77 | 71.2 | 17.2 | NC | 50 (64.9) | 14 (18.2) | 62 (80.5) | 19/(-)/2 | |||
| Janssen et al. [ | S/Retro | GA | 53 | 68 | 15 | NC | NC | NC | 43 (81.1) | (-)/0/(-) | 6 |
| CS | 31 | 73 | 14 | NC | NC | NC | 25 (80.6) | (-)/0/(-) | |||
| Just et al. [ | S/Retro | GA | 42 | 60.4 | 13.4 | NC | NC | 14 (33.3) | NC | 18/(-)/(-) | 7 |
| CS | 67 | 62.9 | 12.9 | NC | NC | 31 (46.3) | NC | 14/(-)/(-) | |||
| Berkhemer et al. [ | M/RCT[ | GA | 79 | 63 | 18[ | 334[ | 67 (84.8) | 18 (22.8) | 41 (51.9) | 17-5-11 | - |
| CS | 137 | 66 | 17[ | 349[ | 120 (87.6) | 52 (38.0) | 86 (62.8) | 27-8-13 | |||
| Löwhagen Hendén et al. [ | S/RCT | GA | 45 | 73 | 20 | 183 | 33 (73.3) | 19 (42.2) | 41 (91.1) | 6/0/(-) | - |
| CS | 45 | 72 | 17 | 180 | 36 (80.0) | 18 (40.0) | 40 (88.9) | 11/3/(-) | |||
| Slezak et al. [ | S/Pro | GA | 266 | 70.9 | 17.2 | 299 | 78 (29.3) | 85 (32.0) | NC | 77/20/67 | 8 |
| CS | 135 | 70.5 | 13.1 | 277 | 44 (32.6) | 64 (47.4) | NC | 28-9-22 |
Values are presented as number (%) unless otherwise indicated.
NIHSS, National Institute of Health Stroke Scale; OPT, onset to puncture time; IV-tPA, intravenous recombinant tissue-type plasminogen activator; S-ICH, symptomatic intracranial hemorrhage; NOS, Newcastle-Ottawa Scale; S, single-center; Retro, retrospective; GA, general anesthesia; NC, not commented; CS, conscious sedation; M, multi-center; Pro, prospective; RCT, randomized controlled trial.
Median value.
33 of 71 patients who were followed-up.
Indicates good outcome or mortality on discharge.
Indicates good outcome or mortality on 1 month follow-up after endovascular treatment.
Indicates post hos analysis of multicenter randomized trials of endovascular treatment for acute ischemic stroke in the Netherlands (MR CLEAN).
Fig. 1.Flow diagram for identification of relevant studies.
Fig. 2.Comparisons of endovascular treatment outcomes according to anesthetic type: general anesthesia (GA) vs. continuous sedation (CS) regarding good functional 3-month outcome (A) and successful recanalization (B) in randomized controlled trials (RCT) or non-RCTs and all studies. OR, odds ratio; CI, confidence interval.
Meta-analysis of secondary outcomes of mortality, S-ICH and pneumonia
| No. of studies | OR GS vs. CS | 95% CI | P-value | I2 | |
|---|---|---|---|---|---|
| Mortality on 3 months | 8 | 1.532 | 1.187-1.976 | 0.001 | 37.948 |
| S-ICH | 7 | 1.125 | 0.767-1.652 | 0.546 | 0 |
| Pneumonia | 7 | 1.613 | 1.172-2.221 | 0.003 | 13.028 |
S-ICH, symptomatic intracranial hemorrhage; OR, odds ratio, GS, general anesthesia; CS, conscious sedation; CI, confidence interval.
Fig. 3.Meta-regression of differences in onset to groin puncture time (OTP, also descried as the time to treatment) and log of odds ratio of good 3-month outcome (A) and successful recanalization (B) in studies included in this meta-analysis. The difference in the mean or median time OTP was used in five or six studies. Each study is represented by a circle, whose size is proportional to that study’s weight in the meta-analysis. The straight line represents the best line of correlation (P=0.95 in A and P=0.94 in B).